2434 related articles for article (PubMed ID: 16916725)
1. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
Gosbell IB; Fernandes LA; Fernandes CJ
Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725
[TBL] [Abstract][Full Text] [Related]
2. [Antimicrobial resistance of Streptococcus pneumoniae, 2003-2009].
Năstase E; Dorneanu O; Dorobăţ C
Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):536-41. PubMed ID: 21870753
[TBL] [Abstract][Full Text] [Related]
3. [Antimicrobial resistance in Streptococcus pneumoniae in Beijing and molecular typing of penicillin-resistant strains].
Wang H; Chen M; Huebener R
Zhonghua Yi Xue Za Zhi; 1999 Apr; 79(4):253-6. PubMed ID: 11601050
[TBL] [Abstract][Full Text] [Related]
4. [Carrier rate of Streptococcus pneumoniae and susceptibility thereof to antimicrobial drugs among children in China: a surveillance study in Beijing, Shanghai, and Guangzhou 2000-2002].
Yao KH; Lu Q; Deng L; Yu SJ; Zhang H; Deng QL; Shen XZ; Yang YH
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(28):1957-61. PubMed ID: 16313770
[TBL] [Abstract][Full Text] [Related]
5. [Antibiotic resistance and serotype distribution of Streptococcus pneumoniae strains isolated from patients at Hacettepe University Medical Faculty].
Yenişehirli G; Sener B
Mikrobiyol Bul; 2003 Jan; 37(1):1-11. PubMed ID: 12838672
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan.
Chen YH; Liu CY; Lu JJ; King CH; Hsueh PR
J Antimicrob Chemother; 2009 Dec; 64(6):1226-9. PubMed ID: 19833635
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae.
Jones RN; Fritsche TR; Sader HS
Diagn Microbiol Infect Dis; 2005 Jun; 52(2):129-33. PubMed ID: 15964501
[TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamic activity of ertapenem versus penicillin-susceptible and penicillin-non-susceptible Streptococcus pneumoniae using an in vitro model.
Zhanel GG; Derkatch S; Laing N; Noreddin AM; Hoban DJ
J Antimicrob Chemother; 2007 Jan; 59(1):144-7. PubMed ID: 17079238
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility of Bacillus anthracis, Bacillus cereus, Bacillus mycoides, Bacillus pseudomycoides and Bacillus thuringiensis to 24 antimicrobials using Sensititre automated microbroth dilution and Etest agar gradient diffusion methods.
Luna VA; King DS; Gulledge J; Cannons AC; Amuso PT; Cattani J
J Antimicrob Chemother; 2007 Sep; 60(3):555-67. PubMed ID: 17586563
[TBL] [Abstract][Full Text] [Related]
10. Emergence of multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1999-2003).
Johnson DM; Stilwell MG; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2006 Sep; 56(1):69-74. PubMed ID: 16546341
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility of Streptococcus pneumoniae, Streptococcus pyogenes and Haemophilus influenzae collected from patients across the USA, in 2001-2002, as part of the PROTEKT US study.
Brown SD; Rybak MJ
J Antimicrob Chemother; 2004 Aug; 54 Suppl 1():i7-15. PubMed ID: 15265831
[TBL] [Abstract][Full Text] [Related]
12. [Resistance to penicillin and other antimicrobials in 301 clinical isolates of Streptococcus pneumoniae].
Navarro C; Egido P; Aspiroz C; Durán E; García C; Rubio C; Gómez-Lus R
Enferm Infecc Microbiol Clin; 2000; 18(7):314-8. PubMed ID: 11109722
[TBL] [Abstract][Full Text] [Related]
13. Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae.
Jones RN; Sader HS; Stilwell MG; Fritsche TR
Diagn Microbiol Infect Dis; 2007 May; 58(1):1-7. PubMed ID: 17408904
[TBL] [Abstract][Full Text] [Related]
14. [Effectiveness of the antibiotics chloramphenicol and rifampin in the treatment of Streptococcus pneumoniae-induced meningitis and systemic infections].
Hernández M; Mejía GI; Trujillo H; Robledo J
Biomedica; 2003 Dec; 23(4):456-61. PubMed ID: 14968923
[TBL] [Abstract][Full Text] [Related]
15. Penicillin resistant Streptococcus pneumoniae isolates in Harare, Zimbabwe.
Simango C; Mvududu F
Cent Afr J Med; 1999 Apr; 45(4):100-2. PubMed ID: 10746390
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial activity among multidrug-resistant Streptococcus pneumoniae isolated in the United States, 2001-2005.
Thornsberry C; Brown NP; Draghi DC; Evangelista AT; Yee YC; Sahm DF
Postgrad Med; 2008 Sep; 120(3 Suppl 1):32-8. PubMed ID: 18931469
[TBL] [Abstract][Full Text] [Related]
17. Molecular epidemiology of penicillin-resistant Streptococcus pneumoniae in a university hospital, Ankara, Turkey.
Pinar A; Köseoğlu O; Yenişehirli G; Sener B
Clin Microbiol Infect; 2004 Aug; 10(8):718-23. PubMed ID: 15301674
[TBL] [Abstract][Full Text] [Related]
18. Comparative activities of beta-lactam antibiotics and quinolones for invasive Streptococcus pneumoniae isolates.
Oncü S; Punar M; Eraksoy H
Chemotherapy; 2004 Jun; 50(2):98-100. PubMed ID: 15211085
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the in vitro activity of pristinamycin and quinupristin/dalfopristin against Streptococcus pneumoniae.
Lozniewski A; Lion C; Mory F; Weber M
Pathol Biol (Paris); 2000 Jun; 48(5):463-6. PubMed ID: 10949841
[TBL] [Abstract][Full Text] [Related]
20. Drug-resistant Streptococcus pneumoniae: the beginning of the end for many antibiotics? Australian Group on Antimicrobial Resistance (AGAR).
Collignon PJ; Bell JM
Med J Aust; 1996 Jan; 164(2):64-7. PubMed ID: 8569573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]